Back
Kailera to Detail Phase 3 Obesity Drug at JP Morgan Conference
Back
Stock News
Themes
Kailera to Detail Phase 3 Obesity Drug at JP Morgan Conference
Asset Management
Kailera to Detail Phase 3 Obesity Drug at JP Morgan Conference
Edgen Stock
·
Dec 23 2025, 22:03
Share to
Share to
Copy link
source:
[1] Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
Recommend
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17
US-China AI Rivalry Enters New Phase Focused on Compute Power and Cybersecurity
Nov 28 2025, 10:17
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17